Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy.
Through the breakthrough device program, Madorra will have priority review and communication regarding the development of the device until the product goes on the market.
Madorra’s handheld device is designed as a prescription, noninvasive home-use device that applies ultrasound waves along the vaginal canal to stimulate local heat and blood flow and produce natural vaginal lubrication to alleviate symptoms of vulvovaginal atrophy (VVA).
Get the full story on our sister site, MassDevice.
"device" - Google News
September 10, 2021 at 03:26AM
https://ift.tt/3yYTLBc
Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device - Medical Design and Outsourcing - Medical Design & Outsourcing
"device" - Google News
https://ift.tt/2KSbrrl
https://ift.tt/2YsSbsy
Bagikan Berita Ini
0 Response to "Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device - Medical Design and Outsourcing - Medical Design & Outsourcing"
Post a Comment